Bid Publish Date
19-Feb-2025, 3:52 pm
Bid End Date
01-Apr-2025, 2:00 pm
EMD
₹1,23,54,300
Location
Progress
A tender has been published for Central Medical Services Society (cmss) BOP Vaccine under Universal Immunization programme of MoHFW (Q1) in SOUTH WEST DELHI, DELHI. Quantity: 397500000 by. Submission Deadline: 01-04-2025 14: 00: 00. Check eligibility and apply.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | HAFFKINE BIO-PHARMACEUTICAL CORPORATION LIMITED Under PMA | Make : Unbranded--HAFFKINE BIO-PHARMACEUTICAL CORPORATION LIMITED Model : Bivalent Oral Poliomyelitis vaccine (bOPV 1 & 3) | 25-03-2025 13:42:55 | |
| 2 | PANACEA BIOTEC LIMITED Under PMA | Make : Bi-OPV Model : Bivalent Poliomyelitis Vaccine Type 1 and Type 3, Live (Oral) | 31-03-2025 18:20:10 | |
| 3 | SAPIGEN BIOLOGIX PRIVATE LIMITED Under PMA | Make : Unbranded--SAPIGEN BIOLOGIX PRIVATE LIMITED Model : Bivalent Poliomyelitis Vaccine Type 1 & 3 - 2 mL | 01-04-2025 12:24:28 |
Quantity
397500000
Category
BOP Vaccine under Universal Immunization programme of MoHFW
Bid Type
Two Packet Bid
Bid Validity
150 (Days)
Bid Type
Service
Evaluation
Item wise evaluation/
Inspection Required
No
Tech Clarification Time
3 Days
Min. Avg. Annual Turnover
9883
OEM Avg. Turnover
9883
Past Performance
40 %
Experience Required
3 Year (s)
Arbitration Clause
No
Mediation Clause
No
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
BOP Vaccine under Universal Immunization programme of MoHFW (Q1)
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
GEM_CATEGORY_SPECIFICATION
OTHER
GEM_CATEGORY_SPECIFICATION
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Extended Deadline
01-Apr-2025, 8:30 am
Opening Date
01-Apr-2025, 9:00 am
Extended Deadline
27-Mar-2025, 9:30 am
Opening Date
27-Mar-2025, 10:00 am
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Key insights about DELHI tender market
The eligibility requirements entail that bidders must be a registered entity according to government norms, possessing a minimum average annual turnover of 9883 Lakh. Additionally, the bidders should have a minimum of 3 years of past experience in supplying vaccine products and have achieved at least 40% in their past performance ratings. Compliance with technical requirements is also mandatory.
Bidders are required to submit various certificates per the instructions in the ATC. Key documents include OEM authorization certificates, compliance documents regarding the Bill of Quantities, and financial documents to validate the bidder’s turnover claim. Ensuring that these documents meet the outlined specifications is crucial for bid acceptance.
To participate in the BOP Vaccine tender, bidders must complete the registration process on the official procurement portal. They will need to provide necessary identification and financial documents. Post-registration, bidders should upload their bid proposals along with the required technical and financial documentation before the stipulated deadline.
For submitting documents related to the BOP Vaccine tender, accepted formats typically include PDF for technical and financial documents. Bidders may need to adhere to specified format requirements detailed in the tender documentation to ensure compliance during the evaluation process.
The payment terms will be outlined in the contract post-award, usually involving advance payments, staged payments upon completion of milestones, and final payments upon delivery confirmation. The evaluation criteria will assess both financial bids and adherence to technical specifications, weighting them accordingly in the final selection process.